Home > Insider Trading > Filing (0000899243-21-007752)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561921	Tela Bio Inc.	TELA	Surgical & Medical Instruments & Apparatus (3841)	455320061

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1746777	Ew Healthcare Partners Fund 2, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	No	Yes
1746779	Ew Healthcare Partners Fund 2-A, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	No	Yes
1793943	Ew Healthcare Partners Fund 2 Gp, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1793948	Ew Healthcare Partners Fund 2-Ugp, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-13	7,002	$13.90	1,482,295	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-14	9,075	$13.96	1,491,370	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-15	763	$13.88	1,492,133	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-26	1,544	$14.24	1,493,677	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-27	5,000	$14.03	1,498,677	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-28	13,950	$13.68	1,512,627	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-01-29	7,760	$13.93	1,520,387	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-02-01	1,119	$14.16	1,521,506	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-02-02	250	$14.08	1,521,756	No	4	P	Indirect	See footnotes
Common Stock, Par Value $0.001 Per Share	Acquisiton	2021-02-04	2,822	$14.29	1,524,578	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes
No	4	P	Indirect	See footnotes

Footnotes

Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:
EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("EW Fund 2-A" and together with EW Fund 2, the "EW Funds"). EW Healthcare Partners Fund 2-UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Partner holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares"). The managers of the General Partner are Martin P. Sutter, Ron Eastman, Scott Barry and Petri Vainio (collectively, the "Managers") and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.